Endothelin-1 is Increased in the Plasma of Patients Hospitalized with Covid-19
George R. Abraham, Rhoda E. Kuc, Magnus Althage, Peter J. Greasley, Philip Ambery, Janet J. Maguire, Ian B. Wilkinson, Stephen P. Hoole, Joseph Cheriyan, Anthony P. Davenport
doi: https://doi.org/10.1101/2021.12.30.21268236
George R. Abraham
aRoyal Papworth Hospital NHS Foundation Trust, Cambridge Biomedical Campus Cambridge, U.K.
bDivision of Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke’s Hospital, Cambridge U.K.
BA BMBCh MRCPRhoda E. Kuc
bDivision of Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke’s Hospital, Cambridge U.K.
GIBiolMagnus Althage
cLate-stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
PhDPeter J. Greasley
cLate-stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
PhDPhilip Ambery
cLate-stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
FRCPJanet J. Maguire
bDivision of Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke’s Hospital, Cambridge U.K.
PhDIan B. Wilkinson
bDivision of Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke’s Hospital, Cambridge U.K.
MA, DM, FRCPStephen P. Hoole
aRoyal Papworth Hospital NHS Foundation Trust, Cambridge Biomedical Campus Cambridge, U.K.
MA, BM, BCh, DM, FRCPJoseph Cheriyan
bDivision of Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke’s Hospital, Cambridge U.K.
dClinical Pharmacology Department and Cardiovascular Office, Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, UK
MBChB MA, FRCPAnthony P. Davenport
bDivision of Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke’s Hospital, Cambridge U.K.
ScDData Availability
All data that support the findings of this study are available from the corresponding author upon reasonable request
Posted January 01, 2022.
Endothelin-1 is Increased in the Plasma of Patients Hospitalized with Covid-19
George R. Abraham, Rhoda E. Kuc, Magnus Althage, Peter J. Greasley, Philip Ambery, Janet J. Maguire, Ian B. Wilkinson, Stephen P. Hoole, Joseph Cheriyan, Anthony P. Davenport
medRxiv 2021.12.30.21268236; doi: https://doi.org/10.1101/2021.12.30.21268236
Endothelin-1 is Increased in the Plasma of Patients Hospitalized with Covid-19
George R. Abraham, Rhoda E. Kuc, Magnus Althage, Peter J. Greasley, Philip Ambery, Janet J. Maguire, Ian B. Wilkinson, Stephen P. Hoole, Joseph Cheriyan, Anthony P. Davenport
medRxiv 2021.12.30.21268236; doi: https://doi.org/10.1101/2021.12.30.21268236
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)